Back to Ethypharm or All Oil Concentrates

Medication Details

Brand
France Ethypharm
Designation
T10:C10
Chemotype
Type II: THC/CBD Mix
Carrier Oil
MCT
THC Potential Range (±10%)
9-11mg
CBD Potential Range (±10%)
9-11mg
Packaged in
Flag of United Kingdom United Kingdom

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Awaiting ETA

Dispensing Pharmacies

Product DescriptionPatient Reviews

France About Ethypharm UK Ltd

Ethypharm Logo

Ethypharm is a specialty pharmaceutical company with European roots, focused on specific Central Nervous System (CNS) diseases and conditions, and on adding value to medicines used in Critical Care situations.

Many of our products are indicated for sensitive situations in which patients either suffer from debilitating conditions such as chronic pain or addiction, or are in a critical state. All around the world, Ethypharm employees are engaged daily to make the difference for patients’ lives by ensuring they are able to receive the right treatment at the right time and with the right support.

Ethypharm is deeply engaged in the CNS and Hospital Injectable areas, where our medicines treat patients today and our teams work on innovative solutions for tomorrow. Willing to grow beyond our recognised positions in the treatment of severe pain and opioid dependency, we are constantly screening opportunities in search for those which will respond to unmet needs in our two core areas.

ethypharm.co.uk

  New government petition approved: Introduce 'Grow Your Own' Laws for Legal Medical Cannabis Patients (CBPM) — please sign and share. 6 months to achieve 10,000 signatures.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)